CGON

CG Oncology, Inc. Common stock

74.62

USD

-1.00

-1.32%

Sep 18, 15:59 UTC -4

Closed

After-Market

72.49

-2.13

-2.85%

CG Oncology, Inc. Common stock Profile

About

CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology is based in IRVINE, Calif.

Info & Links

CEO

Arthur Kuan

Headquarters

400 SPECTRUM CENTER DRIVE, SUITE 2040
IRVINE, CA 92618, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

116

Employees

142

CG Oncology, Inc. Common stock Statistics

Valuation Measures

Market Capitalization²

6.43B

Enterprise Value

6.41B

Enterprise Value/EBITDA(ttm)

-25.57

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.06K

Price to Book(mrq)

6.40

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

-109.90%

Operating Margin(ttm)

-3602.68%

Profit Margin(ttm)

-4200.06%

Return on Equity(ttm)

-25.20%

Return on Invested Capital(ttm)

-24.97%

Return on Assets(ttm)

-23.98%

Income Statement

Revenue(ttm)

6.23M

Revenue Per Share(ttm)

0.07

Gross Profit(ttm)

-5.31M

EBITDA(ttm)³

-250.68M

Net Income Available to Common(ttm)

-224.37M

Diluted EPS(ttm)

-2.69

Share Statistics

Beta (5Y Monthly)

0.24

52-Week Change

97.83%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

88.64M

Dividend Yield

0.00%

Float⁴

84.39M

% Held by Insiders

4.80%

% Held by Institutions

26.56%

Balance Sheet

Total Cash(mrq)

1.03B

Total Cash Per Share(mrq)

11.60

Total Debt(mrq)

3.00M

Total Debt/Equity(mrq)

0.29%

Current Ratio(mrq)

22.22%

Quick Ratio(mrq)

22.20%

Book Value Per Share(mrq)

11.65

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.17

Free Cash Flow(ytd)

-104.13M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.